The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
KAYS · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | KAYS | QURE | LITS | INGN |
|---|---|---|---|---|
| Moat Score (0–100) | 47 (highest) | 47 (highest) | 47 (highest) | 47 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 20 | 53 | 61 (highest) | 59 |
| Pricing power | 69 | 96 (highest) | 70 | 85 |
| Returns on capital | — | 7 | 4 | 11 (highest) |
| Balance-sheet safety | 55 (highest) | 55 (highest) | 55 (highest) | 55 (highest) |
| Capital discipline | 44 (highest) | 24 | 44 (highest) | 24 |
| Price vs. high estimate | No price data | No price data | No price data | No price data |
| Market cap | $8293 | $2.5B | $6.9M | $174.3M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filings as of | FY2024 | FY2025 | FY2025 | FY2025 |